Lymphoma Trial, Recruiting NCT07463989 Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07463989
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 2 years of age
  • People who have been diagnosed with cutaneous lymphoma (a type of cancer that affects the skin)
  • People for whom informed consent has been obtained (a parent or guardian may provide this for younger children)

Who may not be able to join:

  • No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0512144841

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Registry
ClinicalTrials.gov
Start date
13 May 2025
Est. completion
13 May 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To identify potential correlations between cutaneous lymphoma and other factors (including potential areas of high/low incidence and correlations with environmental factors such as pollutants).; To calculate the incidence of various lymphoma subgroups and their stratification by age and sex, to identify geographical areas of high/low incidence and to describe the clinical characteristics of cutaneous lymphomas; To identify the absolute frequency of cutaneous lymphoma based on center admissions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov